410 related articles for article (PubMed ID: 25081544)
21. β-Arrestin-mediated Angiotensin II Signaling Controls the Activation of ARF6 Protein and Endocytosis in Migration of Vascular Smooth Muscle Cells.
Charles R; Namkung Y; Cotton M; Laporte SA; Claing A
J Biol Chem; 2016 Feb; 291(8):3967-81. PubMed ID: 26703465
[TBL] [Abstract][Full Text] [Related]
22. Identification of Distinct Conformations of the Angiotensin-II Type 1 Receptor Associated with the Gq/11 Protein Pathway and the β-Arrestin Pathway Using Molecular Dynamics Simulations.
Cabana J; Holleran B; Leduc R; Escher E; Guillemette G; Lavigne P
J Biol Chem; 2015 Jun; 290(25):15835-15854. PubMed ID: 25934394
[TBL] [Abstract][Full Text] [Related]
23. Protein kinase C and P2Y12 take center stage in thrombin-mediated activation of mammalian target of rapamycin complex 1 in human platelets.
Moore SF; Hunter RW; Hers I
J Thromb Haemost; 2014 May; 12(5):748-60. PubMed ID: 24612393
[TBL] [Abstract][Full Text] [Related]
24. The lipid peroxidation product 4-hydroxy-trans-2-nonenal causes protein synthesis in cardiac myocytes via activated mTORC1-p70S6K-RPS6 signaling.
Calamaras TD; Lee C; Lan F; Ido Y; Siwik DA; Colucci WS
Free Radic Biol Med; 2015 May; 82():137-46. PubMed ID: 25617592
[TBL] [Abstract][Full Text] [Related]
25. Stable interaction between beta-arrestin 2 and angiotensin type 1A receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2.
Wei H; Ahn S; Barnes WG; Lefkowitz RJ
J Biol Chem; 2004 Nov; 279(46):48255-61. PubMed ID: 15355986
[TBL] [Abstract][Full Text] [Related]
26. Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-kinase/serine-threonine protein kinase B/mammalian target of rapamycin/p70 ribosomal S6 kinase 1.
Liu Y; Fanburg BL
Am J Respir Cell Mol Biol; 2006 Feb; 34(2):182-91. PubMed ID: 16195541
[TBL] [Abstract][Full Text] [Related]
27. Src is required for mechanical stretch-induced cardiomyocyte hypertrophy through angiotensin II type 1 receptor-dependent β-arrestin2 pathways.
Wang S; Gong H; Jiang G; Ye Y; Wu J; You J; Zhang G; Sun A; Komuro I; Ge J; Zou Y
PLoS One; 2014; 9(4):e92926. PubMed ID: 24699426
[TBL] [Abstract][Full Text] [Related]
28. Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance.
Violin JD; DeWire SM; Yamashita D; Rominger DH; Nguyen L; Schiller K; Whalen EJ; Gowen M; Lark MW
J Pharmacol Exp Ther; 2010 Dec; 335(3):572-9. PubMed ID: 20801892
[TBL] [Abstract][Full Text] [Related]
29. Effects of rapamycin on cell proliferation and phosphorylation of mTOR and p70(S6K) in HepG2 and HepG2 cells overexpressing constitutively active Akt/PKB.
Varma S; Khandelwal RL
Biochim Biophys Acta; 2007 Jan; 1770(1):71-8. PubMed ID: 16952420
[TBL] [Abstract][Full Text] [Related]
30. β-Arrestin signal complex plays a critical role in adipose differentiation.
Santos-Zas I; Lodeiro M; Gurriarán-Rodríguez U; Bouzo-Lorenzo M; Mosteiro CS; Casanueva FF; Casabiell X; Pazos Y; Camiña JP
Int J Biochem Cell Biol; 2013 Jul; 45(7):1281-92. PubMed ID: 23557604
[TBL] [Abstract][Full Text] [Related]
31. Role of beta-arrestin-mediated desensitization and signaling in the control of angiotensin AT1a receptor-stimulated transcription.
Lee MH; El-Shewy HM; Luttrell DK; Luttrell LM
J Biol Chem; 2008 Jan; 283(4):2088-97. PubMed ID: 18006496
[TBL] [Abstract][Full Text] [Related]
32. Ezrin, radixin, and moesin phosphorylation in NIH3T3 cells revealed angiotensin II type 1 receptor cell-type-dependent biased signaling.
Ibrahim IA; Nakaya M; Kurose H
J Pharmacol Sci; 2013; 122(1):1-9. PubMed ID: 23575451
[TBL] [Abstract][Full Text] [Related]
33. β-Arrestin regulation of myosin light chain phosphorylation promotes AT1aR-mediated cell contraction and migration.
Simard E; Kovacs JJ; Miller WE; Kim J; Grandbois M; Lefkowitz RJ
PLoS One; 2013; 8(11):e80532. PubMed ID: 24255721
[TBL] [Abstract][Full Text] [Related]
34. Characterization of pomiferin triacetate as a novel mTOR and translation inhibitor.
Bajer MM; Kunze MM; Blees JS; Bokesch HR; Chen H; Brauss TF; Dong Z; Gustafson KR; Biondi RM; Henrich CJ; McMahon JB; Colburn NH; Schmid T; Brüne B
Biochem Pharmacol; 2014 Apr; 88(3):313-21. PubMed ID: 24513322
[TBL] [Abstract][Full Text] [Related]
35. Crosstalk between VEGFR2 and muscarinic receptors regulates the mTOR pathway in serum starved SK-N-SH human neuroblastoma cells.
Edelstein J; Hao T; Cao Q; Morales L; Rockwell P
Cell Signal; 2011 Jan; 23(1):239-48. PubMed ID: 20851763
[TBL] [Abstract][Full Text] [Related]
36. Akt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (mammalian target of rapamycin) by IκB kinase α (IKKα).
Dan HC; Ebbs A; Pasparakis M; Van Dyke T; Basseres DS; Baldwin AS
J Biol Chem; 2014 Sep; 289(36):25227-40. PubMed ID: 24990947
[TBL] [Abstract][Full Text] [Related]
37. Early endosomal antigen 1 (EEA1) is an obligate scaffold for angiotensin II-induced, PKC-alpha-dependent Akt activation in endosomes.
Nazarewicz RR; Salazar G; Patrushev N; San Martin A; Hilenski L; Xiong S; Alexander RW
J Biol Chem; 2011 Jan; 286(4):2886-95. PubMed ID: 21097843
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin II Receptor Type 1 Antagonists Modulate Vascular Smooth Muscle Cell Proliferation and Migration via AMPK/mTOR.
Zhao Y; Shang F; Shi W; Zhang J; Zhang J; Liu X; Li B; Hu X; Wang L
Cardiology; 2019; 143(1):1-10. PubMed ID: 31307032
[TBL] [Abstract][Full Text] [Related]
39. Vascular dysfunction in human and rat cirrhosis: role of receptor-desensitizing and calcium-sensitizing proteins.
Hennenberg M; Trebicka J; Biecker E; Schepke M; Sauerbruch T; Heller J
Hepatology; 2007 Feb; 45(2):495-506. PubMed ID: 17256744
[TBL] [Abstract][Full Text] [Related]
40. ASCT2 silencing regulates mammalian target-of-rapamycin growth and survival signaling in human hepatoma cells.
Fuchs BC; Finger RE; Onan MC; Bode BP
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C55-63. PubMed ID: 17329400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
